Switch theme
Sign up to access all valuation multiples
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.
2020
360
LTM Revenue $1.4B
LTM EBITDA -$95.9M
$176M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
P3 Health Partners has a last 12-month revenue (LTM) of $1.4B and a last 12-month EBITDA of -$95.9M.
In the most recent fiscal year, P3 Health Partners achieved revenue of $1.5B and an EBITDA of -$198M.
P3 Health Partners expects next 12-month revenue of XXX and NTM EBITDA of XXX
See P3 Health Partners valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.4B | XXX | $1.5B | XXX | XXX | XXX |
| Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| Gross Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA | -$95.9M | XXX | -$198M | XXX | XXX | XXX |
| EBITDA Margin | -7% | XXX | -13% | XXX | XXX | XXX |
| EBIT | -$192M | XXX | -$313M | XXX | XXX | XXX |
| EBIT Margin | -13% | XXX | -21% | XXX | XXX | XXX |
| Net Profit | -$134M | XXX | -$136M | XXX | XXX | XXX |
| Net Margin | -9% | XXX | -9% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $116M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of August 18, 2025, P3 Health Partners's stock price is $7.
P3 Health Partners has current market cap of $22.1M, and EV of $176M.
See P3 Health Partners trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $176M | $22.1M | XXX | XXX | XXX | XXX | $-31.34 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of August 18, 2025, P3 Health Partners has market cap of $22.1M and EV of $176M.
P3 Health Partners's trades at 0.1x EV/Revenue multiple, and -0.9x EV/EBITDA.
Equity research analysts estimate P3 Health Partners's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
P3 Health Partners has a P/E ratio of -0.2x.
See valuation multiples for P3 Health Partners and 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $22.1M | XXX | $22.1M | XXX | XXX | XXX |
| EV (current) | $176M | XXX | $176M | XXX | XXX | XXX |
| EV/Revenue | 0.1x | XXX | 0.1x | XXX | XXX | XXX |
| EV/EBITDA | -1.8x | XXX | -0.9x | XXX | XXX | XXX |
| EV/EBIT | -0.9x | XXX | -0.6x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | -0.2x | XXX | -0.2x | XXX | XXX | XXX |
| EV/FCF | -2.0x | XXX | -1.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialP3 Health Partners's last 12 month revenue growth is 3%
P3 Health Partners's revenue per employee in the last FY averaged $4.2M, while opex per employee averaged $5.0M for the same period.
P3 Health Partners's rule of 40 is -3% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
P3 Health Partners's rule of X is 1% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for P3 Health Partners and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 3% | XXX | 1% | XXX | XXX | XXX |
| EBITDA Margin | -7% | XXX | -13% | XXX | XXX | XXX |
| EBITDA Growth | -66% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -3% | XXX | -10% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 1% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $4.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $5.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 0% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 121% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| National Healthcare Corp | XXX | XXX | XXX | XXX | XXX | XXX |
| Regis Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Maternus-Kliniken | XXX | XXX | XXX | XXX | XXX | XXX |
| Addus HomeCare | XXX | XXX | XXX | XXX | XXX | XXX |
| Amedisys | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
P3 Health Partners acquired XXX companies to date.
Last acquisition by P3 Health Partners was XXXXXXXX, XXXXX XXXXX XXXXXX . P3 Health Partners acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was P3 Health Partners founded? | P3 Health Partners was founded in 2020. |
| Where is P3 Health Partners headquartered? | P3 Health Partners is headquartered in United States of America. |
| How many employees does P3 Health Partners have? | As of today, P3 Health Partners has 360 employees. |
| Who is the CEO of P3 Health Partners? | P3 Health Partners's CEO is Dr. Aric Coffman, M.D.. |
| Is P3 Health Partners publicy listed? | Yes, P3 Health Partners is a public company listed on NAS. |
| What is the stock symbol of P3 Health Partners? | P3 Health Partners trades under PIII ticker. |
| When did P3 Health Partners go public? | P3 Health Partners went public in 2021. |
| Who are competitors of P3 Health Partners? | Similar companies to P3 Health Partners include e.g. National Healthcare Corp, Regis Healthcare, Maternus-Kliniken, Addus HomeCare. |
| What is the current market cap of P3 Health Partners? | P3 Health Partners's current market cap is $22.1M |
| What is the current revenue of P3 Health Partners? | P3 Health Partners's last 12 months revenue is $1.4B. |
| What is the current revenue growth of P3 Health Partners? | P3 Health Partners revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of P3 Health Partners? | Current revenue multiple of P3 Health Partners is 0.1x. |
| Is P3 Health Partners profitable? | Yes, P3 Health Partners is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of P3 Health Partners? | P3 Health Partners's last 12 months EBITDA is -$95.9M. |
| What is P3 Health Partners's EBITDA margin? | P3 Health Partners's last 12 months EBITDA margin is -7%. |
| What is the current EV/EBITDA multiple of P3 Health Partners? | Current EBITDA multiple of P3 Health Partners is -1.8x. |
| What is the current FCF of P3 Health Partners? | P3 Health Partners's last 12 months FCF is -$87.9M. |
| What is P3 Health Partners's FCF margin? | P3 Health Partners's last 12 months FCF margin is -6%. |
| What is the current EV/FCF multiple of P3 Health Partners? | Current FCF multiple of P3 Health Partners is -2.0x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
